BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 12683867)

  • 1. Management of patients refractory to platelet transfusion.
    Sacher RA; Kickler TS; Schiffer CA; Sherman LA; Bracey AW; Shulman IA;
    Arch Pathol Lab Med; 2003 Apr; 127(4):409-14. PubMed ID: 12683867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The definition of refractoriness to platelet transfusions.
    Bishop JF; Matthews JP; Yuen K; McGrath K; Wolf MM; Szer J
    Transfus Med; 1992 Mar; 2(1):35-41. PubMed ID: 1308461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prophylactic platelet transfusion for prevention of bleeding in patients with haematological disorders after chemotherapy and stem cell transplantation.
    Estcourt L; Stanworth S; Doree C; Hopewell S; Murphy MF; Tinmouth A; Heddle N
    Cochrane Database Syst Rev; 2012 May; (5):CD004269. PubMed ID: 22592695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Guidelines for platelet transfusions. British Committee for Standards in Haematology, Working Party of the Blood Transfusion Task Force.
    Murphy MF; Brozovic B; Murphy W; Ouwehand W; Waters AH
    Transfus Med; 1992 Dec; 2(4):311-8. PubMed ID: 1339584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Refractoriness to platelet transfusion.
    Rebulla P
    Curr Opin Hematol; 2002 Nov; 9(6):516-20. PubMed ID: 12394175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathogen-reduced platelets for the prevention of bleeding.
    Butler C; Doree C; Estcourt LJ; Trivella M; Hopewell S; Brunskill SJ; Stanworth S; Murphy MF
    Cochrane Database Syst Rev; 2013 Mar; (3):CD009072. PubMed ID: 23543569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prophylactic platelet transfusion for haemorrhage after chemotherapy and stem cell transplantation.
    Stanworth SJ; Hyde C; Heddle N; Rebulla P; Brunskill S; Murphy MF
    Cochrane Database Syst Rev; 2004 Oct; (4):CD004269. PubMed ID: 15495093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet transfusion refractoriness.
    Hod E; Schwartz J
    Br J Haematol; 2008 Jul; 142(3):348-60. PubMed ID: 18510692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical aspects of platelet transfusions.
    Murphy MF; Waters AH
    Blood Coagul Fibrinolysis; 1991 Apr; 2(2):389-96. PubMed ID: 1893071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New paradigms in the management of alloimmune refractoriness to platelet transfusions.
    Vassallo RR
    Curr Opin Hematol; 2007 Nov; 14(6):655-63. PubMed ID: 17898571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical aspects of platelet transfusion therapy.
    Murphy MF
    Infusionsther Transfusionsmed; 1994 Nov; 21 Suppl 3():34-8. PubMed ID: 7841778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet transfusion trigger in difficult patients.
    Rebulla P
    Transfus Clin Biol; 2001 Jun; 8(3):249-54. PubMed ID: 11499971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet transfusions: the problem of refractoriness.
    Murphy MF; Waters AH
    Blood Rev; 1990 Mar; 4(1):16-24. PubMed ID: 2182145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bacterial contamination of platelet units: a case report and literature survey with review of upcoming american association of blood banks requirements.
    Burns KH; Werch JB
    Arch Pathol Lab Med; 2004 Mar; 128(3):279-81. PubMed ID: 14987162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HLA-selected platelets for platelet refractory patients with HLA antibodies: a single-center experience.
    Karlström C; Linjama T; Edgren G; Lauronen J; Wikman A; Höglund P
    Transfusion; 2019 Mar; 59(3):945-952. PubMed ID: 30575964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet transfusions for patients with haematological malignancies: who needs them?
    Estcourt LJ; Stanworth SJ; Murphy MF
    Br J Haematol; 2011 Aug; 154(4):425-40. PubMed ID: 21615375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet transfusions: treatment options for hemorrhage secondary to thrombocytopenia.
    Hux BD; Martin LG
    J Vet Emerg Crit Care (San Antonio); 2012 Feb; 22(1):73-80. PubMed ID: 23016744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnosis and management of refractoriness to platelet transfusion.
    Schiffer CA
    Blood Rev; 2001 Dec; 15(4):175-80. PubMed ID: 11792118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet transfusion for patients with cancer: clinical practice guidelines of the American Society of Clinical Oncology.
    Schiffer CA; Anderson KC; Bennett CL; Bernstein S; Elting LS; Goldsmith M; Goldstein M; Hume H; McCullough JJ; McIntyre RE; Powell BL; Rainey JM; Rowley SD; Rebulla P; Troner MB; Wagnon AH;
    J Clin Oncol; 2001 Mar; 19(5):1519-38. PubMed ID: 11230498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet Transfusion in Critical Care and Surgery: Evidence-Based Review of Contemporary Practice and Future Directions.
    Etchill EW; Myers SP; Raval JS; Hassoune A; SenGupta A; Neal MD
    Shock; 2017 May; 47(5):537-549. PubMed ID: 27849676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.